Literature DB >> 3240726

Influence of ketanserin on glucose and lipid metabolism in diabetic patients with hypertension.

H U Janka1, H Mehnert, R Fisher, K U Seiler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3240726     DOI: 10.2165/00003495-198800361-00024

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  5 in total

1.  Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

Authors:  M J Garcia; P M McNamara; T Gordon; W B Kannel
Journal:  Diabetes       Date:  1974-02       Impact factor: 9.461

Review 2.  Pharmacological control of platelet and red blood cell function in the microcirculation.

Authors:  F De Clerck; J L David
Journal:  J Cardiovasc Pharmacol       Date:  1981 Nov-Dec       Impact factor: 3.105

3.  Some aspects of hypertension in diabetes mellitus.

Authors:  S Pell; C A D'Alonzo
Journal:  JAMA       Date:  1967-10-02       Impact factor: 56.272

4.  Effects of ketanserin, a 5-HT2-receptor antagonist, on the blood flow response to temperature changes in the diabetic foot.

Authors:  S H Schneider; M Tendler; A Apelian; A H Jageneau; A K Khachadurian
Journal:  J Clin Pharmacol       Date:  1985-09       Impact factor: 3.126

5.  Do antihypertensive drugs precipitate diabetes?

Authors:  C Bengtsson; G Blohmé; L Lapidus; O Lindquist; H Lundgren; E Nyström; K Petersen; J A Sigurdsson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-01
  5 in total
  1 in total

Review 1.  Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.